Filing Details
- Accession Number:
- 0001628280-24-046753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-08 18:00:55
- Reporting Period:
- 2024-11-06
- Accepted Time:
- 2024-11-08 18:00:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611311 | P. David Rosenbaum | C/O Ardelyx, Inc. 400 Fifth Avenue, Suite 210 Waltham MA 02451 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-06 | 27,171 | $2.32 | 180,787 | No | 4 | M | Indirect | By Wife |
Common Stock | Disposition | 2024-11-06 | 27,171 | $6.10 | 153,616 | No | 4 | S | Indirect | By Wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By Wife |
No | 4 | S | Indirect | By Wife |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-06 | 27,171 | $0.00 | 27,171 | $2.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2029-01-17 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 301,946 | Direct | |
Common Stock | 77,592 | Indirect | Family Trust |
Footnotes
- The shares are directly held by the Reporting Person's wife.
- The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
- The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.